MRVFF
Price:
$0.9795
Market Cap:
$301.70B
Nuvo Pharmaceuticals Inc., which operates globally under the trade name Miravo Healthcare, specializes in delivering both prescription and over-the-counter medical products. The company's diverse portfolio addresses key therapeutic areas, including pain management, allergy relief, neurological conditions, and dermatological concerns. Its operations are structured into three distinct business units: a Commercial division, a Production and Service division, and a Licensing and Royalty division. Among its significant offerings are Blexten, an antihistamine prescribed for the symptomatic treatment of allergic rhinitis and chronic spontaneous urticaria; Cambia, a nonsteroidal anti-inflammatory dr...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-04-26
Stock Exchange
OTC
Ticker
MRVFF
According to Nuvo Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -19.59. This represents a change of -137.59% compared to the average of 52.11 of the last 4 quarters.
The mean historical PE Ratio of Nuvo Pharmaceuticals Inc. over the last ten years is 14.89. The current -19.59 PE Ratio has changed -13257.16% with respect to the historical average. Over the past ten years (40 quarters), MRVFF's PE Ratio was at its highest in in the September 2022 quarter at 167.51. The PE Ratio was at its lowest in in the March 2018 quarter at -450.33.
Average
14.89
Median
-13.12
Minimum
-72.54
Maximum
192.13
Discovering the peaks and valleys of Nuvo Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 169.71%
Maximum Annual PE Ratio = 192.13
Minimum Annual Increase = -691.69%
Minimum Annual PE Ratio = -72.54
| Year | PE Ratio | Change |
|---|---|---|
| 2021 | -9.30 | -87.18% |
| 2020 | -72.54 | -181.40% |
| 2019 | 89.11 | -282.19% |
| 2018 | -48.91 | -125.46% |
| 2017 | 192.13 | 169.71% |
| 2016 | 71.24 | -276.25% |
| 2015 | -40.42 | -691.69% |
| 2014 | 6.83 | -130.60% |
| 2013 | -22.32 | 31.80% |
| 2012 | -16.94 | -33.49% |
The current PE Ratio of Nuvo Pharmaceuticals Inc. (MRVFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.42
5-year avg
30.10
10-year avg
14.89
Nuvo Pharmaceuticals Inc.’s PE Ratio is less than RIV Capital Inc. (-0.11), less than MGC Pharmaceuticals Limited (-0.06), less than Antibe Therapeutics Inc. (-0.79), less than Verici Dx plc (-0.18), less than Living Cell Technologies Limited (-11.55), less than LexaGene Holdings Inc. (0), less than Red White & Bloom Brands Inc. (-0.13), less than The Flowr Corporation (0), less than Simply Better Brands Corp. (-5.71), less than RAMM Pharma Corp. (-0.21),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.11 | $10.96M | |
| -0.06 | $12.11M | |
| -0.79 | $11.43M | |
| -0.18 | $4.54M | |
| -11.55 | $11.39M | |
| 0 | $11.34M | |
| -0.13 | $13.71M | |
| 0 | $4.26K | |
| -5.71 | $14.81M | |
| -0.21 | $15.16M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuvo Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nuvo Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nuvo Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Nuvo Pharmaceuticals Inc. (MRVFF)?
What is the highest PE Ratio for Nuvo Pharmaceuticals Inc. (MRVFF)?
What is the 3-year average PE Ratio for Nuvo Pharmaceuticals Inc. (MRVFF)?
What is the 5-year average PE Ratio for Nuvo Pharmaceuticals Inc. (MRVFF)?
How does the current PE Ratio for Nuvo Pharmaceuticals Inc. (MRVFF) compare to its historical average?